Japan Tob (OTCMKTS:JAPAY) Sees Strong Trading Volume – Here’s Why

Japan Tob (OTCMKTS:JAPAY) saw strong trading volume on Tuesday. 122,851 shares were traded during trading, a decline of 1% from the previous session’s volume of 124,003 shares. The stock last traded at $23.21 and had previously closed at $22.91.

Wall Street Analyst Weigh In

Separately, BTIG Research assumed coverage on shares of Japan Tob in a research note on Wednesday, July 22nd. They set a “buy” rating on the stock. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Japan Tob presently has a consensus rating of “Hold” and a consensus price target of $17.00.

Japan Tob Trading Up 0.8%

The stock has a 50-day moving average of $21.91 and a 200 day moving average of $20.08. The company has a quick ratio of 1.45, a current ratio of 2.04 and a debt-to-equity ratio of 0.35. The stock has a market cap of $81.93 billion, a PE ratio of 16.84, a price-to-earnings-growth ratio of 1.52 and a beta of 0.28.

Japan Tob (OTCMKTS:JAPAY) last posted its quarterly earnings results on Thursday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.33 by $0.08. The business had revenue of $6.67 billion for the quarter, compared to analysts’ expectations of $6.15 billion. As a group, sell-side analysts anticipate that Japan Tob will post 1.13 earnings per share for the current year.

About Japan Tob

Japan Tobacco Inc is a Japan-based company engaged primarily in the manufacture and sale of tobacco products. Its portfolio includes combustible cigarettes, heated tobacco products and other reduced-risk nicotine products marketed under brands such as Winston, MEVIUS, Camel and Ploom. The company serves consumers in Japan and international markets through its tobacco business.

In addition to tobacco, Japan Tobacco operates businesses in pharmaceuticals and processed foods. Its pharmaceutical activities focus on prescription medicines, while its food operations include products such as frozen foods, seasonings and processed food ingredients.